VP, Deputy General Counsel, Legal
Adam is a biopharmaceutical lawyer with deep Commercial, R&D, transactional, regulatory and compliance experience, spanning 25+ years.
During his career, Adam has helped launch multiple new drugs/biologics, while providing leadership and legal guidance to cross-functional and global teams. Most recently, he served as Senior Compliance Counsel at EMD Serono, where he had U.S. and Global responsibilities. Prior to that, he was Lead Counsel for GE Healthcare’s one-billion-dollar pharmaceutical-diagnostics business. He also spent about seven years at Biogen, including serving as its Lead Rare Disease Lawyer. Adam began his career at the law firm of Hale and Dorr (now Wilmerhale).
Adam has a J.D. from Boston University School of Law and a B.A. from Rutgers College. In addition, he holds professional certifications from Seton Hall Law School and Harvard Business School.